Simris Alg AB (publ) (SIMRIS-B) - Cash Flow Conversion Efficiency

Latest as of June 2026: -3.330x

Based on the latest financial reports, Simris Alg AB (publ) (SIMRIS-B) has a cash flow conversion efficiency ratio of -3.330x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.55 Million ≈ $-274.85K USD) by net assets (Skr767.00K ≈ $82.54K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Simris Alg AB (publ) for the company's overall valuation and market capitalisation.

Simris Alg AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Simris Alg AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Simris Alg AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Simris Alg AB (publ) ranked by their cash flow conversion efficiency. See SIMRIS-B operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Scage Future American Depositary Shares
NASDAQ:SCAG
0.142x
Pergamon Status Dis Ticaret AS
IS:PSDTC
-0.002x
HYUNGJI INNOVATION & CREATIVE Co.Ltd
KQ:011080
-0.071x
SUNL.TECH.G.ADR/2DL-00005
F:S790
N/A
BOA Resources Ltd
AU:BOA
-0.089x
Samjin LND Co. Ltd
KQ:054090
0.065x
Cairn Homes PLC
LSE:CRN
-0.155x
J and Friends Holdings Limited
NASDAQ:JF
-43.621x

Annual Cash Flow Conversion Efficiency for Simris Alg AB (publ) (2014–2025)

The table below shows the annual cash flow conversion efficiency of Simris Alg AB (publ) from 2014 to 2025. View latest Simris Alg AB (publ) stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr-470.00K
≈ $-50.58K
Skr-16.05 Million
≈ $-1.73 Million
34.138x +1168.91%
2024-12-31 Skr5.64 Million
≈ $607.06K
Skr-18.02 Million
≈ $-1.94 Million
-3.194x -125.03%
2023-12-31 Skr25.61 Million
≈ $2.76 Million
Skr-36.35 Million
≈ $-3.91 Million
-1.419x -79.74%
2022-12-31 Skr23.03 Million
≈ $2.48 Million
Skr-18.19 Million
≈ $-1.96 Million
-0.790x +20.67%
2021-12-31 Skr18.22 Million
≈ $1.96 Million
Skr-18.14 Million
≈ $-1.95 Million
-0.995x -142.26%
2020-12-31 Skr47.42 Million
≈ $5.10 Million
Skr-19.48 Million
≈ $-2.10 Million
-0.411x +16.96%
2019-12-31 Skr35.00 Million
≈ $3.77 Million
Skr-17.32 Million
≈ $-1.86 Million
-0.495x +11.61%
2018-12-31 Skr39.78 Million
≈ $4.28 Million
Skr-22.27 Million
≈ $-2.40 Million
-0.560x -1.15%
2017-12-31 Skr42.68 Million
≈ $4.59 Million
Skr-23.62 Million
≈ $-2.54 Million
-0.553x -93.91%
2016-12-31 Skr65.32 Million
≈ $7.03 Million
Skr-18.64 Million
≈ $-2.01 Million
-0.285x -32.17%
2015-12-31 Skr38.68 Million
≈ $4.16 Million
Skr-8.35 Million
≈ $-898.81K
-0.216x +75.83%
2014-12-31 Skr9.78 Million
≈ $1.05 Million
Skr-8.73 Million
≈ $-939.92K
-0.893x --

About Simris Alg AB (publ)

ST:SIMRIS-B Sweden Biotechnology
Market Cap
$17.07 Million
Skr158.60 Million SEK
Market Cap Rank
#25692 Global
#519 in Sweden
Share Price
Skr0.12
Change (1 day)
+0.43%
52-Week Range
Skr0.04 - Skr0.17
All Time High
Skr14.17
About

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammen… Read more